IP Library Granted Patent US 11,713,332
Granted Patent B2
US 11,713,332 · App. 16/317,304 · Granted Aug 1, 2023

Metal complexes

Inventors: Philipp Stoessel (Frankfurt am Main, DE); Christian Ehrenreich (Darmstadt, DE)
Assignee: Merck Patent GmbH
C07F15/0033H10K50/156H10K50/16H10K85/342H10K50/11H10K2101/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,713,332
App. No.
16/317,304
Granted
Aug 1, 2023
Kind
B2
Abstract

The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, containing these metal complexes.

Claims (56)

1. A monometallic compound comprising a hexadentate tripodal ligand wherein three bidentate part-ligands, which may be identical or different, are coordinated to a metal selected from the group consisting of ruthenium, osmium, rhodium and iridium, and the three bidentate part-ligands are linked to one another via a bridge of formula (1):

wherein

the dashed bonds are the direct bonds from the bidentate part-ligands to the structure of formula (1);

X 1 is on each occurrence, identically or differently, CR 2 or O;

X 2 is on each occurrence, identically or differently, CR, P═O, B, or Si, which is optionally substituted, with the proviso that, when X 2 is P═O, B, or Si, which is optionally substituted, X 1 is O; and wherein substituents optionally present on X 1 and X 2 optionally define an aliphatic or heteroaliphatic ring system with themselves or with one another;

X 3 is on each occurrence, identically or differently, —CR═CR—, —CR═N—, —CR—NR″—, —C(═O)—O—, —C(═O)—NR″—, —C(═O)—S—, —C(═S)—O—, —C(═S)—S—;

R is on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(R 1 ) 2 , CN, NO 2 , OR 1 , SR 1 , COOH, C(═O)N(R 1 ) 2 , Si(R 1 ) 3 , B(OR 1 ) 2 , C(═O)R 1 , P(═O)(R 1 ) 2 , S(═O)R 1 , S(═O) 2 R 1 , OSO 2 R 1 , a straight-chain alkyl group having 1 to 20 C atoms or an alkenyl or alkynyl group having 2 to 20 C atoms or a branched or cyclic alkyl group having 3 to 20 C atoms, wherein the alkyl, alkenyl, or alkynyl group in each case is optionally substituted by one or more radicals R 1 , wherein one or more non-adjacent CH 2 groups are optionally replaced by R 1 C═CR 1 , C═C, Si(R 1 ) 2 , C═O, NR 1 , O, S, or CONR 1 , or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which in each case is optionally substituted by one or more radicals R 1 ; and wherein two or more radicals R which are bonded to X 1 and/or X 2 optionally define an aliphatic or heteroaliphatic ring system with one another; and wherein two radicals R when X 3 is —CR═CR— optionally define an aliphatic, heteroaliphatic, aromatic, or heteroaromatic ring system with one another; and wherein radicals R and R″ when X 3 is —CR—NR″— define a heteroaromatic ring system with one another;

R″ is on each occurrence, identically or differently, H, D, a straight-chain alkyl group having 1 to 20 C atoms or a branched or cyclic alkyl group having 3 to 20 C atoms or an alkenyl group having 2 to 20 C atoms, wherein the alkyl or alkenyl group in each case is optionally substituted by one or more radicals R 1 and wherein one or more non-adjacent CH 2 groups are optionally replaced by Si(R 1 ) 2 , or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which in each case is optionally substituted by one or more radicals R′;

R 1 is on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(R 2 ) 2 , CN, NO 2 , OR 2 , SR 2 , Si(R 2 ) 3 , B(OR 2 ) 2 , C(═O)R 2 , P(═O)(R 2 ) 2 , S(═O)R 2 , S(═O) 2 R 2 , OSO 2 R 2 , a straight-chain alkyl group having 1 to 20 C atoms or an alkenyl or alkynyl group having 2 to 20 C atoms or a branched or cyclic alkyl group having 3 to 20 C atoms, wherein the alkyl, alkenyl, or alkynyl group in each case is optionally substituted by one or more radicals R 2 , wherein one or more non-adjacent CH 2 groups are optionally replaced by R 2 C═CR 2 , C≡C, Si(R 2 ) 2 , C═O, NR 2 , O, S, or CONR 2 , or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which in each case is optionally substituted by one or more radicals R 2 ; wherein a plurality of substituents R 1 optionally define an aliphatic, heteroaliphatic, aromatic, or heteroaromatic ring system with one another;

furthermore, the groups R or R substituted with R 1 optionally form a ring system, and groups R and R 1 optionally form a ring system with one another;

R 2 is on each occurrence, identically or differently, H, D, F, or an aliphatic, aromatic, and/or heteroaromatic organic radical having 1 to 20 C atoms, wherein one or more H atoms are optionally replaced by F; and

wherein the bidentate part-ligands are selected, identically or differently on each occurrence, from the group consisting of structures of formulae (L-1), (L-2), (L-3), and (L-4):

wherein

the dashed bond is the direct bond from the part-ligand to the bridge of formula (1);

CyC is, identically or differently on each occurrence, an optionally substituted aryl or heteroaryl group having 5 to 14 aromatic ring atoms, which is coordinated to the metal via a carbon atom and which is connected to CyD via a covalent bond;

CyD is, identically or differently on each occurrence, an optionally substituted heteroaryl group having 5 to 14 aromatic ring atoms, which is coordinated to the metal via a nitrogen atom or via a carbene carbon atom and which is connected to CyC via a covalent bond; and

wherein a plurality of the optional substituents optionally defines a ring system with one another; and

the three bidentate ligands are optionally cyclised by a further bridge, in addition to the bridge of formula (1), to define a cryptate.

2. The monometallic compound of claim 1 , wherein the bridge of formula (1) is selected from the group consisting of structures of formulae (2) through (6):

wherein

R′ is on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(R 1 ) 2 , CN, NO 2 , OR′, SR′, COOH, C(═O)N(R 1 ) 2 , C(═O)R 1 , P(═O)(R 1 ) 2 , S(═O)R 1 , S(═O) 2 R 1 , OSO 2 R 1 , a straight-chain alkyl group having 1 to 20 C atoms or an alkenyl or alkynyl group having 2 to 20 C atoms or a branched or cyclic alkyl group having 3 to 20 C atoms, where the alkyl, alkenyl, or alkynyl group in each case is optionally substituted by one or more radicals R′, wherein one or more non-adjacent CH 2 groups are optionally replaced by R 1 C═CR 1 , C≡C, C═O, NR 1 , O, S, or CONR 1 , or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which in each case are optionally substituted by one or more radicals R 1 .

3. The monometallic compound of claim 1 , wherein the bridge of formula (1) is selected from the structures of the formulae (2a) and (2b)

4. The monometallic compound of claim 1 , wherein the bidentate part-ligands are each monoanionic and wherein the three bidentate part-ligands are either selected identically or two bidentate part-ligands are selected identically and the third bidentate part-ligand is selected differently from the first two bidentate part-ligands and wherein the coordinating atoms of the bidentate part-ligands are selected, identically or differently on each occurrence, from C, and/or N.

5. The monometallic compound of claim 1 , wherein the metal is Ir(III) and two of the bidentate part-ligands are coordinated to the iridium in each case via one carbon atom and one nitrogen atom or via two carbon atoms and the third of the bidentate part-ligands is coordinated to the iridium via one carbon atom and one nitrogen atom or via two carbon atoms or via two nitrogen atoms.

6. The monometallic compound of claim 1 wherein CyC is selected from the group consisting of structures of formulae (CyC-1) through (CyC-20):

wherein

the group is in each case bonded to CyD in (L-1) or (L-2) or to CyC in (L-4) at the position denoted by # and is coordinated to the metal at the position denoted by *; and

CyD is selected from the group consisting of structures of formulae (CyD-1) through (CyD-14):

wherein

the group is in each case bonded to CyC in (L-1) or (L-2) or to CyD in (L-3) at the position denoted by # and is coordinated to the metal at the position denoted by *; and

wherein

R is on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(R 1 ) 2 , CN, NO 2 , OR 1 , SR 1 , COOH, C(═O)N(R 1 ) 2 , Si(R 1 ) 3 , B(OR 1 ) 2 , C(═O)R 1 , P(═O)(R 1 ) 2 , S(═O)R 1 , S(═O) 2 R 1 , OSO 2 R 1 , a straight-chain alkyl group having 1 to 20 C atoms or an alkenyl or alkynyl group having 2 to 20 C atoms or a branched or cyclic alkyl group having 3 to 20 C atoms, wherein the alkyl, alkenyl, or alkynyl group in each case is optionally substituted by one or more radicals R 1 , wherein one or more non-adjacent CH 2 groups are optionally replaced by R 1 C=CR 1 , C═C, Si(R 1 ) 2 , C═O, NR 1 , O, S, or CONR 1 , or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which in each case is optionally substituted by one or more radicals R 1 ; and wherein two or more radicals R which are bonded to X 1 and/or X 2 optionally define an aliphatic or heteroaliphatic ring system with one another; and wherein two radicals R when X 3 is —CR═CR— optionally define an aliphatic, heteroaliphatic, aromatic, or heteroaromatic ring system with one another; and wherein radicals R and R″ when X 3 is —CR—NR″— define a heteroaromatic ring system with one another; and wherein two radicals R optionally define an aliphatic, heteroaliphatic, aromatic, or heteroaromatic ring system with one another:

X is on each occurrence, identically or differently, CR or N, with the proviso that a maximum of two X per ring are N;

W is on each occurrence, identically or differently, NR, O, or S; and

wherein the bonding of these groups to the bridge of formula (1) is via the position denoted by “o” and the corresponding X is C.

7. The monometallic compound of claim 1 , wherein the bidentate part-ligands are selected from the group consisting of structure of formulae (L-1-1), (L-1-2), (L-2-1), (L-2-2), (L-2-3), and (L-5) through (L-34):

8. The monometallic compound of claim 1 , wherein the monometallic compound comprises two substituents R, which are bonded to adjacent carbon atoms and which define a ring of one of formulae (43) through (49) with one another:

wherein

the dashed bonds indicate the linking of the two carbon atoms in the ligand;

A 1 and A 3

are, identically or differently on each occurrence, C(R 3 ) 2 , O, S, NR 3 , or C(=0);

A 2 is C(R 1 ) 2 , 0, S, NR 3 , or C(═O);

G is an alkylene group having 1, 2, or 3 C atoms, which is optionally substituted by one or more radicals R 2 , or is —CR 2 ═CR 2 — or an ortho-linked arylene or heteroarylene group having 5 to 14 aromatic ring atoms, which is optionally substituted by one or more radicals R 2 ;

R 3 is, identically or differently on each occurrence, H, D, F, a straight-chain alkyl or alkoxy group having 1 to 10 C atoms, a branched or cyclic alkyl or alkoxy group having 3 to 10 C atoms, wherein the alkyl or alkoxy group in each case is optionally substituted by one or more radicals R 2 , wherein one or more non-adjacent CH 2 groups are optionally replaced by R 2 C═CR 2 , C═C, Si(R 2 ) 2 , C═O, NR 2 , O, S, or CONR 2 , or an aromatic or heteroaromatic ring system having 5 to 24 aromatic ring atoms, which in each case is optionally substituted by one or more radicals R 2 , or an aryloxy or heteroaryloxy group having 5 to 24 aromatic ring atoms, which is optionally substituted by one or more radicals R 2 ; and wherein two radicals R 3 bonded to the same carbon atom optionally define an aliphatic or aromatic ring system with one another to form a spiro system; and wherein R 3 optionally defines an aliphatic ring system with an adjacent radical R or R 1 , with the proviso that no two heteroatoms are bonded directly to one another and no two groups C═O are bonded directly to one another in these groups.

9. A process for preparing the monometallic compound of claim 1 , comprising reacting a free ligand with a metal alkoxides of formula (50), a metal ketoketonate of formula (51), a metal halide of formula (52), or a metal carboxylate of formula (53), or with a metal compound which carries both alkoxide and/or halide and/or hydroxyl and also ketoketonate radicals:

wherein

M is the metal of the monometallic compound being prepared;

n is the valency of the metal M; and

Hal is F, Cl, Br, or I; and

wherein the metal starting materials are optionally in the form of a corresponding hydrate.

10. An oligomer, polymer, or dendrimer comprising one or more monometallic compounds of claim 1 , wherein one or more bonds from the monometallic compound to the polymer, oligomer, or dendrimer are present instead of one or more hydrogen atoms and/or substituents.

11. A formulation comprising at least one monometallic compound of claim 1 and at least one solvent.

12. A formulation comprising at least one oligomer, polymer, or dendrimer of claim 10 and at least one solvent.

13. An electronic device comprising at least one monometallic compound of claim 1 .

14. An electronic device comprising at least one oligomer, polymer, or dendrimer of claim 10 .

15. The electronic device of claim 13 , wherein the electronic device is an organic electroluminescent device and the at least one monometallic compound is employed as an emitting compound in one or more emitting layers or as a hole-blocking material in a hole blocking layer or as an electron-transport material in an electron-transport layer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: MERCK PATENT GMBH
To: UDC IRELAND LIMITED
Reel/Frame 064004/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2019
From: STOESSEL, PHILIPP; EHRENREICH, CHRISTIAN
To: MERCK PATENT GMBH
Reel/Frame 048049/0609 →
Priority Claims (1)
EP 16179378 · Jul 14, 2016 · regional
Continuity (1)
Related Publication 20190315787A1 · Oct 17, 2019